CytoVeris
Business Services · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Farmington Ave, Farmington, Connecti...Phone Number
(203) 631-1966Website
www.cytoveris.comRevenue
$8.8 MillionIndustry
About CytoVeris
CytoVeris Org Chart
Is CytoVeris your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if CytoVeris is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once CytoVeris has new funding data
Product Launch: Get notified when CytoVeris launches new products
Check if CytoVeris has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
CytoVeris, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at CytoVeris
Click to see if CytoVeris had a recent Job posting/layoffs
Earning: See what the market has to say on CytoVeris recently announced quarterly report
Recommended Actions
Find VP level buyers at CytoVeris
Find more new buyers
Compare Similar Companies to CytoVeris
Compare insights from companies similar to CytoVeris, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CytoVeris is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CytoVeris is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CytoVeris.
CytoVeris financials insights
Gather financial insights about CytoVeris, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$218K
CytoVeris Tech Stack
A closer look at the technologies used by CytoVeris
CytoVeris News & Media
CytoVeris Publishes Preclinical Study Showing Potential of its...
The study demonstrates that the TumorMAP system is suitable for the detection of breast cancer (PRWeb February 07, 2023) Read the full story at https://www.prweb.com/releases/cytoveris_publishes_preclinical_study_showing_potential_of_its_tumormap_system_for_cancer_detection/prweb19155500.htmCytoVeris Awarded National Cancer Institute Small Business Innovation...
Grant will be used to validate the company’s AI-powered technology for improving treatment options and outcomes for patients diagnosed with bladder cancer (PRWeb November 01, 2021) Read the full story at https://www.prweb.com/releases/cytoveris_awarded_national_cancer_institute_small_business_innovation_research_phase_1_grant/prweb18300519.htmCytoVeris Acceptance into NVIDIA Inception to Accelerate Go-To-Market Efforts
Startup to leverage benefits from NVIDIA Inception, including access to technology and expertise, to advance development and commercialization of smart imaging platform (PRWeb September 01, 2021) Read the full story at https://www.prweb.com/releases/cytoveris_acceptance_into_nvidia_inception_to_accelerate_go_to_market_efforts/prweb18166594.htmCytoVeris Announces Addition of Scott Flora to Board of Directors
A prominent global leader with over 40 years medical device experience, Flora joins biotechnology company in mission to enhance the clinical outcomes of cancer patients (PRWeb August 26, 2021) Read the full story at https://www.prweb.com/releases/cytoveris_announces_addition_of_scott_flora_to_board_of_directors/prweb18154160.htm
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding CytoVeris
With a passion for science and compassion for cancer patients, CytoVeris is leveraging the convergence of powerful optical technologies, knowledge of biochemical alteration during carcinogenesis, and artificial intelligence to bring new capabilities into the hands of surgeons, improving outcomes and accessibility for surgeons and patients alike. Th... Read More